Clinical Trials
4 trialsNCT05136196 2026-06-05
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT02834013 2026-06-03
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT06897735 2026-06-03
EDDIS-a1
Petrov, Andrey
Phase 1 Terminated
NCT07124000 2026-06-01
DP-04
AstraZeneca
Recruiting